CA2080355A1 - Isolated Viral Protein Cytokine Antagonists - Google Patents

Isolated Viral Protein Cytokine Antagonists

Info

Publication number
CA2080355A1
CA2080355A1 CA 2080355 CA2080355A CA2080355A1 CA 2080355 A1 CA2080355 A1 CA 2080355A1 CA 2080355 CA2080355 CA 2080355 CA 2080355 A CA2080355 A CA 2080355A CA 2080355 A1 CA2080355 A1 CA 2080355A1
Authority
CA
Canada
Prior art keywords
cytokine antagonists
isolated viral
viral protein
protein cytokine
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2080355
Other languages
French (fr)
Other versions
CA2080355C (en
Inventor
Craig A. Smith
Raymond G. Goodwin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2080355A1 publication Critical patent/CA2080355A1/en
Application granted granted Critical
Publication of CA2080355C publication Critical patent/CA2080355C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Isolated viral proteins, and pharmaceutical compositions made therefrom, are disclosed which are capable of binding to cytokines, thereby functioning as cytokine antagonists. Also disclosed are processes for preparing isolated viral protein cytokine antagonists.
CA 2080355 1990-04-09 1991-03-29 Isolated viral protein cytokine antagonists Expired - Fee Related CA2080355C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50721390A 1990-04-09 1990-04-09
US07/507,213 1990-04-09

Publications (2)

Publication Number Publication Date
CA2080355A1 true CA2080355A1 (en) 1991-10-10
CA2080355C CA2080355C (en) 1999-03-09

Family

ID=24017699

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2080355 Expired - Fee Related CA2080355C (en) 1990-04-09 1991-03-29 Isolated viral protein cytokine antagonists

Country Status (2)

Country Link
CA (1) CA2080355C (en)
IE (1) IE911108A1 (en)

Also Published As

Publication number Publication date
CA2080355C (en) 1999-03-09
IE911108A1 (en) 1991-10-23

Similar Documents

Publication Publication Date Title
DK0604418T3 (en) Isolated viral protein cytokine antagonists
CA2178752A1 (en) N-Terminally Chemically Modified Protein Compositions and Methods
AU628696B2 (en) Heterocyclic substituted acylaminothiazoles, their preparation and pharmaceutical compositions containing them
IL92558A0 (en) Pharmaceutical compositions comprising pyrimidine derivatives,certain novel such derivatives and their preparation
ZA872867B (en) 5-arylalkyl-4-alkoxy-2(5h)-furanones,intermediates and processes for the preparation thereof and pharmaceutical compositions containing them
CA2116764A1 (en) Immunoreactive Hepatitis C Virus Polypeptide Compositions
CA2075358A1 (en) Multimers of the soluble forms of tnf receptors, their preparation and pharmaceutical compositions containing them
WO1999012964A3 (en) Kay - a novel immune system protein
FI874706L (en) Method for preparing stable pharmaceutical compositions of non-glycosylated recombinant interferon
NZ234854A (en) Quinoline derivatives, preparation, intermediates and pharmaceutical compositions thereof
IL86782A0 (en) Amino acid derivatives,processes for the preparation thereof and pharmaceutical compositions comprising the same
IL85136A0 (en) Peptide derivatives,their preparation and pharmaceutical compositions containing them
IL73466A (en) Atrial peptides,their preparation and pharmaceutical compositions comprising them
AU1365788A (en) Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
EP0897987A3 (en) Secretion of human protein linked to gamma interferon signal peptide
FR2681326B1 (en) NOVEL PEPTIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS.
AU7227587A (en) Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
HUT61048A (en) Cytokine synthesis inhibiting factor, its antagonists and their application
IL74222A (en) 6-substituted-4-dialkylamino tetrahydrobenz(c,d)indoles,their preparation and pharmaceutical compositions comprising them
IL82231A0 (en) 1-hydroxy-2-pyridones,process for their preparation,and pharmaceutical compositions which contain them and intermediates formed in the preparation of the 1-hydroxy-2-pyridones
CA2041818A1 (en) Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof as pharmaceutical compositions or as performance enhancers
CA2123315A1 (en) Therapeutic agents which are antagonists or partial agonists of human interleukin 4
CA2056437A1 (en) Production of virus and purification of viral envelope proteins for vaccine use
CA2141555A1 (en) Morphogenic protein soluble complex and composition thereof
IL81833A (en) Renin inhibitory peptides,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed